Jim Simons Vericel Corp Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Vericel Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 134,492 shares of VCEL stock, worth $6.17 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

134,492

Previous 78,192 72.0%

Holding current value

$6.17 Million

Previous $2.78 Million 151.29%

% of portfolio

0.01%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$32.52 - $52.33 $1.83 Million - $2.95 Million	56,300 Added 72.0%	134,492 $7 Million
Q4 2023 Feb 13, 2024	BUY	$30.85 - $37.09 $838,873 - $1.01 Million	27,192 Added 53.32%	78,192 $2.78 Million
Q3 2023 Nov 14, 2023	BUY	$31.69 - $39.25 $1.62 Million - $2 Million	51,000 New	51,000 $1.71 Million
Q2 2021 Aug 13, 2021	SELL	$47.2 - $67.81 $429,142 - $616,528	-9,092 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$30.93 - $59.48 $290,742 - $559,112	-9,400 Reduced 50.83%	9,092 $505,000

Q4 2020 Feb 10, 2021	BUY	$18.53 - $31.5 $342,656 - $582,498	18,492 New	18,492 $571,000
Q3 2020 Nov 13, 2020	SELL	$14.68 - $19.12 $769,114 - $1 Million	-52,392 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$8.5 - $15.82 $287,886 - $535,807	-33,869 Reduced 39.26%	52,392 $724,000
Q1 2020 May 14, 2020	BUY	$7.25 - $19.22 $625,392 - $1.66 Million	86,261 New	86,261 $791,000
Q2 2019 Aug 12, 2019	SELL	$15.01 - $18.89 $5.42 Million - $6.82 Million	-361,092 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$16.23 - $20.29 $1.02 Million - $1.28 Million	63,100 Added 21.18%	361,092 $6.32 Million
Q4 2018 Feb 13, 2019	BUY	$10.77 - $18.44 $3.21 Million - $5.49 Million	297,992 New	297,992 $5.19 Million

Others Institutions Holding VCEL

# of Institutions

263

Shares Held

48.9M

Call Options Held

150K

Put Options Held

128K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.16B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account